These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6422008)

  • 1. Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.
    Abeloff MD; Slavik M; Luk GD; Griffin CA; Hermann J; Blanc O; Sjoerdsma A; Baylin SB
    J Clin Oncol; 1984 Feb; 2(2):124-30. PubMed ID: 6422008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.
    Abeloff MD; Rosen ST; Luk GD; Baylin SB; Zeltzman M; Sjoerdsma A
    Cancer Treat Rep; 1986 Jul; 70(7):843-5. PubMed ID: 3013400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithine.
    Griffin CA; Slavik M; Chien SC; Hermann J; Thompson G; Blanc O; Luk GD; Baylin SB; Abeloff MD
    Invest New Drugs; 1987; 5(2):177-86. PubMed ID: 3115911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bis(guanylhydrazone)].
    Warrell RP; Coonley CJ; Burchenal JH
    Cancer Chemother Pharmacol; 1983; 11(2):134-6. PubMed ID: 6414731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of intravenous difluoromethylornithine--a polyamine inhibitor.
    Maddox AM; Keating MJ; McCredie KE; Estey E; Freireich EJ
    Invest New Drugs; 1985; 3(3):287-92. PubMed ID: 3934106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients.
    Talpaz M; Plager C; Quesada J; Benjamin R; Kantarjian H; Gutterman J
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):685-9. PubMed ID: 3091371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
    O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
    Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
    Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
    Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.
    Love RR; Carbone PP; Verma AK; Gilmore D; Carey P; Tutsch KD; Pomplun M; Wilding G
    J Natl Cancer Inst; 1993 May; 85(9):732-7. PubMed ID: 8478959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of alpha-difluoromethylornithine and methyl-GAG.
    Splinter TA; Romijn JC
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):61-7. PubMed ID: 3082642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
    Oredsson SM; Deen DF; Marton LJ
    Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tissue ornithine increases the cytotoxicity of difluoromethylornithine.
    Grossie VB; Nishioka K
    Anticancer Res; 1996; 16(6B):3731-5. PubMed ID: 9042249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD; Fleischmann J; Tackett RE; Ratliff TL
    Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
    Alhonen-Hongisto L; Levin VA; Marton LJ
    Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
    Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
    Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma.
    Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA
    Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
    Takigawa M; Verma AK; Simsiman RC; Boutwell RK
    Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anchorage dependency effects on difluoromethylornithine cytotoxicity in human lung carcinoma cells.
    Luk GD; Baylin SB
    Cancer Res; 1986 Apr; 46(4 Pt 1):1844-8. PubMed ID: 3004707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
    Luk GD; Abeloff MD; Griffin CA; Baylin SB
    Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion.
    Seidenfeld J; Komar KA
    Cancer Res; 1985 May; 45(5):2132-8. PubMed ID: 3921237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.